Dr Matera reviews recent evidence that has demonstrated the potential renal protection offered by sodium glucose co-transporter 2 inhibitors against diabetic kidney disease.
Neal Barnard, MD, President of the Physicians Committee for Responsible Medicine, discusses evidence on the key role of plant-based eating patterns in the treatment of diabetes, as well as the importance of...
Kim Carmichael, MD, from the Washington University School of Medicine in St. Louis, discusses his column, “What Do You Need to Know About Diabetic Gastroparesis?”
In this podcast, Lucia Novak reflects on how the ACP's 2018 HbA1c guidelines have impacted the landscape of diabetes care over the past year, and discusses the importance of individualized treatment.
Lucia Novak, director of Riverside Diabetes Center, gives strategies that may help improve diabetes management and prevent clinical inertia on patient and practitioner levels.
Lucia Novak, director of Riverside Diabetes Center, discusses the benefits of long-acting insulins and barriers that may prevent more widespread implementation of these therapies.
Lucia Novak, director of Riverside Diabetes Center in Maryland, defines clinical inertia and outlines patient- and practitioner-level factors that may impede appropriate management of your patients’...
Kevin Stewart, director of Environmental Health, Advocacy, and Public Policy at the American Lung Association of the Mid-Atlantic, explains the dangers of radon as the second-leading cause of lung cancer in...
Dr Mikhail Kosiborod from Saint Luke's Cardiovascular Consultants discusses the cardiologist's role in treating diabetes, when a diabetes specialist should be consulted, and the overall takeaway for...
